Cargando…
Mitochondrial CPT1A: Insights into structure, function, and basis for drug development
Carnitine Palmitoyl-Transferase1A (CPT1A) is the rate-limiting enzyme in the fatty acid β-oxidation, and its deficiency or abnormal regulation can result in diseases like metabolic disorders and various cancers. Therefore, CPT1A is a desirable drug target for clinical therapy. The deep comprehension...
Autor principal: | Liang, Kai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10076611/ https://www.ncbi.nlm.nih.gov/pubmed/37033619 http://dx.doi.org/10.3389/fphar.2023.1160440 |
Ejemplares similares
-
In Silico Prediction and Insights Into the Structural Basis of Drug Induced Nephrotoxicity
por: Shi, Yinping, et al.
Publicado: (2022) -
Quantitative proteomics reveals Polygonum perfoliatum L. ameliorates hepatic steatosis by promoting PPARs/CPT1A/CPT2-mediated fatty acid β-oxidation
por: Liu, Guanjie, et al.
Publicado: (2023) -
HuangQin Decoction Attenuates CPT-11-Induced Gastrointestinal Toxicity by Regulating Bile Acids Metabolism Homeostasis
por: Wang, Xu, et al.
Publicado: (2017) -
Endocannabinoid basis of personality—Insights from animal model of social behavior
por: Kogan, Natalya M., et al.
Publicado: (2023) -
Structural Insights Into the High Selectivity of the Anti-Diabetic Drug Mitiglinide
por: Wang, Mengmeng, et al.
Publicado: (2022)